Risk of retinal vein occlusion between GLP-1 receptor agonists and DPP-4 inhibitors in type 2 diabetes: a retrospective cohort study
Foundayo is a once-daily pill classified as an oral small-molecule GLP-1 receptor agonist, with a different chemical structure from injectable GLP-1 drugs like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound), and from oral semaglutide (Rybelsus, the Wegovy pill), which belongs to the same peptide class as the injectables
FOR SUDDEN SPIKES IN BLOOD SUGAR SOURCE: Collins L, Costello RA
The glucagon arm is what sets it apart from anything else clinically available
Much kinder to your insides
There is increasing enthusiasm around the potential for retatrutide to prevent obesity, particularly in those who are at high risk